Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorJanice Hernandez, MD
About this trial
This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.
Eligibility criteria
Qualifiers
Patients >18 years of age
follow-up at specified intervals (1 week/6 week/3 months) in an office setting
can give informed consent
no patients will be excluded on the basis of gender, ethnicity, or religious background
Disqualifiers
Patients <18 years of age or >100
allergy to pectin, gelatin, and sodium carboxymethylcellulose
adults with impaired consent capacity
incarcerated individuals.
Trial design
Treatments tested in this trial
- Hydrocolloid Wound Dressing
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Janice Hernandez, MD
Lead sponsor
University of Kentucky
Sponsor institution
Source ClinicalTrials.gov